Discuss Nektar Therapeutics
Nektar Therapeutics
WKN: 165417 / Symbol: NKTR / Name: Nektar / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
0,58 €
2,03 %
Nektar Therapeutics (NASDAQ:NKTR) had its price target raised by analysts at B. Riley from $85.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for NKTR provided by MarketBeat
Nektar Therapeutics (NASDAQ:NKTR) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NKTR provided by MarketBeat
Nektar Therapeutics (NASDAQ:NKTR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $102.00 price target on the stock.
Ratings data for NKTR provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Teva Pharmaceutical Industries Ltd ADR diskutieren